WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RYTM past revenue growth

How has RYTM's revenue growth performed historically?
Company
227.56%
Industry
151.46%
Market
17.61%
RYTM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RYTM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RYTM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RYTM earnings and revenue history

Current Revenue
$77.4M
Current Earnings
-$184.7M
Current Profit Margin
-238.5%

RYTM Return on Equity

Current Company
-96%
Current Industry
-63.5%
Current Market
188%
RYTM's Return on Equity (-96%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RYTM announces earnings.

RYTM Return on Assets

Current Company
-55%
Current Industry
2.9%
RYTM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RYTM Return on Capital Employed

Current Company
-61.33%
Current Industry
19.5%
RYTM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RYTM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RYTM$77.43M-$168.46M-$184.68M+395.47%N/A
DNLI$330.53M-$128.47M-$145.22M+20.67%N/A
ARVN$78.50M-$359.70M-$367.30M+40.53%N/A
MRUS$43.95M-$163.72M-$154.94M+2.75%N/A
CORT$482.38M$109.00M$105.50M+13.93%+9.43%
View Top Biotech Stocks

RYTM earnings dates

Next earnings date
Apr 30, 2024

Rhythm Pharmaceuticals Earnings & Revenue FAQ

What were RYTM's earnings last quarter?

On Invalid Date, Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q4 2023 earnings per share (EPS) of -$0.70, up 5.41% year over year. Total Rhythm Pharmaceuticals earnings for the quarter were -$41.63 million. In the same quarter last year, Rhythm Pharmaceuticals's earnings per share (EPS) was -$0.74.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.

What was RYTM's earnings growth in the past year?

As of Q2 2024, Rhythm Pharmaceuticals's earnings has grown year over year. Rhythm Pharmaceuticals's earnings in the past year totalled -$184.68 million.

What is RYTM's earnings date?

Rhythm Pharmaceuticals's earnings date is Invalid Date. Add RYTM to your watchlist to be reminded of RYTM's next earnings announcement.

What was RYTM's revenue last quarter?

On Invalid Date, Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q4 2023 revenue of $24.23 million up 175.7% year over year. In the same quarter last year, Rhythm Pharmaceuticals's revenue was $8.79 million.

What was RYTM's revenue growth in the past year?

As of Q2 2024, Rhythm Pharmaceuticals's revenue has grown 227.56% year over year. This is 76.1 percentage points higher than the US Biotechnology industry revenue growth rate of 151.46%. Rhythm Pharmaceuticals's revenue in the past year totalled $77.43 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.